Hyperlipidaemia in diabetes

Australian Prescriber

Volumn 22, Issue 3, 1999, Pages 67-69

  Can, Seng Khee ^a   Yuen, Ronnie W M ^b   Welborn, Timothy A ^c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Atherosclerosis; Cholesterol; Insulin; Metabolic syndrome; Triglyceride

Indexed keywords

BEZAFIBRATE; ESTROGEN; FIBRIC ACID DERIVATIVE; FISH OIL; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PRAVASTATIN; SIMVASTATIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; ESTROGEN THERAPY; EXERCISE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; SCREENING TEST; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0033017158     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.1999.057     Document Type: Article

References (9)

1. Stamler J, Vaccaro O, Neaton JD. Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993:16:434-44.
2. Ginsberg HN. Lipoprotein physiology in non-diabetic and diabetic states. Relationship to atherogenesis. Diabetes Care 1991:14:839-55.
3. Syvanne M, Taskinen MR. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 1997:350 Suppl 1:120-3.
4. Austin MA, Breslow JL. Hennekens CH, Birring JE, Willen WC. Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988:260:1917-21.
5. Pyorala K, Pedersen TR, Kjekshus J. Faergeman O, Olsson AG. Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) [published erratum appears in Diabetes Care 1997:20:1048J. Diabetes Care 1997:20:614-20.
6. Sacks FM, Pfeffer MA. Moye LA, Rouleau JL, Rutherford JD, Cole TG. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996:335:1001-9.
7. Koskinen P, Mannttari M. Manninen V, Huttunen JK, Heinonen OP. Frick MH. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 1992:15:820-5.
8. Best JD. Jerums G, Newnham HH, O'Brien RC. Diabetic dyslipidaemia. Australian Diabetes Society position statement. Med J Aust 1995:162:91-3.
9. Haffner SM. American Diabetes Association. Management of dyslipidaemia in adults with diabetes. Diabetes Care 1998:21:160-82.